🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
This is a prospective, non-interventional, post marketing surveillance stud...
Status
Completed
Location
Research Site
Start Date
2008-02
Trial ID
NCT00622323
No head to head comparisons between exenatide once weekly and liraglutide h...
Status
Completed
Location
Research Site
Start Date
2010-01
Trial ID
NCT01029886
Treatments Being Tested
The purpose of this research was to assess the absolute and relative incide...
Status
Completed
Location
Research Site
Start Date
2004-09
Trial ID
NCT01077323
Treatments Being Tested
Exenatide twice daily has been studied in Japanese type 2 diabetes patients...
Status
Completed
Location
Research Site
Start Date
2007-09
Trial ID
NCT00612794
Treatments Being Tested
This study will compare the efficacy and safety of exenatide versus placebo...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00765817
Patients undergoing open heart surgery are at risk of suffering damage to t...
Status
Active Not Recruiting
Location
Rigshospitalet - Copenhagen University Hospital
Start Date
2016-02
Trial ID
NCT02673931
Treatments Being Tested
The purpose of this study is to compare the effects of 2.0 mg exenatide onc...
Status
Completed
Location
Research Site
Start Date
2008-04
Trial ID
NCT00641056
Treatments Being Tested
The primary purpose of this study is to assess the anti-exenatide-antibody ...
Status
Completed
Location
Research Site
Start Date
2007-08
Trial ID
NCT00516048
Treatments Being Tested
A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Exami...
Status
Completed
Location
Research Site 182
Start Date
2006-04
Trial ID
NCT00308139
Treatments Being Tested